CURATIVE Domain 1: defining @ risk Flashcards
goal of Domain 1 was
association bw conditions ID as potential risk factors
provide the basis for prescribing recommendations
diseases evaluated, a high risk for thrombosis:
Low or moderate risk for thrombosis:
- immune‐mediated hemolytic anemia
- protein‐losing nephropathy
- cats with cardiomyopathy AND associated risk factors
(hx ATE, dilated LA, smoke) - dogs/cats with >1 disease w risk factor for thrombosis
- dogs or cats with a single risk factor (aside from IMHA, PLN, HCM + risks factors)
- known risk factor likely to resolve in days to weeks following treatment
1.1 Immune‐mediated hemolytic anemia (dogs only)
association:
prophy tx?
MoA of hyper coag
LOE
strongly associated w develop of thrombosis in dogs
recommend antithrombotic therapy for dogs with IMHA
increased TF expression, plt activation, procoagulant microparticles, and neutrophil extracellular traps
13/13 panel members responding agreed (round 2).
Three retrospective studies (LOE 5, Good)
1.2 Protein‐losing nephropathy (dogs only)
association:
prophy tx?
LOE
incidence:
IS associated w development of thrombosis in dogs
recommend antithrombotic therapy for dogs with PLN
13/13 panel members responding agreed (round 2).
17 studies (LOE 2–5, Good‐Fair)
lack control group, precluding clear cause and effect
6% to 42% of dogs
1.3 Pancreatitis (dogs only)
association:
prophy tx?
LOE
MAY be associated w. develop of thrombosis in dogs
suggest that antithrombotic therapy be considered
-acute pancreatic necrosis + concurrent prothrombotic conditions are present
Delphi process: 13/13 panel members responding agreed (LOE 2–5, Poor)
frequent presence of comorbidities in published reports also complicates the assessment of the association between pancreatitis and thrombosis in dogs
1.4 Glucocorticoid administration (dogs only)
association:
prophy tx?
LOE
may be associated
suggest that antithrombotic therapy + other risk factors
Delphi process: 13/13 panel members responding agreed (LOE 5, Good‐Fair)
1.5 Hyperadrenocorticism (dogs only)
IS associated with the development of thrombosis
suggest HAC alone does not warrant antithrombotic unless other risk factors for thrombosis exist
Delphi process: 13/13 panel members responding
- 6 Cancer (dogs only)
- 7 Sepsis (dogs only)
- 8 Cerebrovascular disease
- 10 Canine heart disease
in particular (adeno)carcinoma, is associated with the development of thrombosis in a small subset of dogs only
There is insufficient evidence +
considered where other risk factors for thrombosis exist
insufficient evidence
considered where hypercoag demon. other risk factors for thrombosis exist
disease is more likely to result from a thrombotic event rather than be the cause of one
suggest that antithrombotic therapy be considered when an ischemic stroke is identified and a concurrent medical condition associated with a risk for thrombosis is present
NOT associated
considered where hypercoag demon. other risk factors for thrombosis exist
1.9 Heart disease (cats)
incidence
strongly associated with a risk of ATE
Cats with a history of: ATE left atrial (LA) dilation spontaneous echocontrast reduced LA appendage flow velocity -particular risk
We recommend antithrombotic therapy for cats with cardiomyopathy, PLUS risk factors
Delphi process: 12/13 panel members responding agreed (LOE 2–4, Good‐Fair)
cumulative risk of ATE at 1, 5, and 10 years was 3.5%, 9.5%, and 11.3%, respectively
- 11 We define high risk for thrombosis as
1. 12 We define low/moderate risk for thrombosis as
Dogs with - 1. IMHA 2. PLN
Cats - 3. cardiomyopathy PLUS risk factors
- Dogs or cats with >1 disease/risk factor for thrombosis (eg, pancreatitis with sepsis)
Dogs or cats with a single risk factor/disease
Dogs or cats with known risk factor conditions that, with treatment, are likely to resolve in days to weeks